This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Medimmune Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mark Esser - Innovator in Infection Control
Introduction
Mark Esser is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of infection control through his innovative research and development efforts. His work focuses on methods to decrease infections in patients colonized with specific pathogens.
Latest Patents
Mark Esser holds 1 patent titled "Decreasing infections in colonized patients." This patent discloses methods of treating subjects colonized with an anti-alpha toxin antibody or an antigen-binding fragment thereof. The methods aim to decrease the incidence of infection associated with the presence of the subject.
Career Highlights
Mark Esser is currently employed at MedImmune Limited, a leading biotechnology company. His role involves extensive research and development aimed at improving patient outcomes through innovative therapeutic solutions.
Collaborations
Mark has collaborated with several talented individuals in his field, including Kathryn Shoemaker and Hasan Jafri. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Mark Esser's work in infection control exemplifies the impact of innovative thinking in healthcare. His contributions continue to pave the way for advancements in treatment methodologies.